biomedicina slovenica

"HYDROXYMETHYLGLUTARYL COA REDUCTASES" : 54

  1. Conklin Daniel J; Prough Russell A; Juvan Peter; Režen Tadeja; Rozman Damjana; Haberzettl Petra; Srivastava Sanjay; Bhatnagar Aruni
    Acrolein-induced dyslipidemia and acute-phase response are independent of HMG-CoA reductase
    2011 ►
  2. Plemenitaš Ana; Gunde-Cimerman Nina
    Molecular mechanisms of adaptations to high salt concentration in the extremely halotolerant black yeast Hortaea werneckii
    2011 ►
  3. Lunder Mojca; Žiberna Lovro; Drevenšek Gorazd; Šabovič Mišo
    Zaščitni pleiotropni učinki statinov
    [Beneficial pleiotropic effects of statins]
    2011 ►
  4. Vaupotič T; Veranič P; Petrovič U; Gunde-Cimerman N; Plemenitaš A
    HMG-CoA reductase is regulated by environmental salinity and its activity is essential for halotolerance in halophilic fungi
    2008 ►
  5. Vaupotič Tomaž; Plemenitaš Ana
    Osmoadaptation-dependent activity of microsomal HMG-CoA reductase in the extremely halotolerant black yeast Hortaea werneckii is regulated by ubiquitination
    2007 ►
  6. Nissen Steven E; Nicholls Stephen J; Sipahi Ilke; Libby Peter; Raichlen Joel S; Ballantyne Christie M; Davignon Jean; Erbel Raymond; Fruchart Jean-Charles; Tardif Jean-Claude
    Učinki zelo intenzivne terapije s statini na zmanjšanje obsega koronarne ateroskleroze: študija ASTEROID
    [Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial]
    2006 ►
  7. Okrajšek Renata
    Učinki zdravljenja z atorvastatinom pri bolnikih z napredovalnim srčnim popuščanjem
    2006 ►
  8. Herman Darja; Locatelli Igor; Grabnar Iztok; Peternel Polona; Stegnar Mojca; Lainščak Mitja; Mrhar Aleš; Breskvar Katja; Dolžan Vita
    The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintance dose
    2006 ►
  9. Goličnik Alenka; Ferjan Mateja
    Vpliv atorvastatina na trajanje intervala QTc pri bolnikih s srčnim popuščanjem
    [Effect of atorvastatin on QTc interval duration in patients with heart failure]
    2006 ►
  10. Šabovič Mišo
    Zdravljenje stabilne angine pektoris s statini
    2006 ►
  11. Vrtovec Bojan; Okrajšek Renata; Goličnik Alenka; Ferjan Mateja; Starc Vito; Radovancevic Branislav
    Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure
    2005 ►
  12. Cevc Matija
    Lipidi in rak - soodvisnost? Vpliv hipolipemikov in indikacije za njihovo uporabo pri rakavih bolnikih
    2006 ►
  13. Plemenitaš Ana; Gunde-Cimerman Nina
    Cellular responses in the halophilic black yeast Hortaea werneckii to high environmental salinity
    2005 ►
  14. Pintar Tatjana
    Vpliv statinov na pooperativne zaplete pri bolnikih po kirurški revaskularizaciji venčnih arterij
    2005 ►
  15. Nissen Steven E; Tuzcu E Murat; Schoenhagen Paul; Brown B Greg; Ganz Peter; Vogel Robert A; Crowe Tim; Howard Gail; Cooper Christopher J; Brodie Bruce
    Primerjava učinkov intenzivnega in zmernega protilipidnega zdravljenja na napredovanje korornarne ateroskleroze: randomizirana nadzorovana študija
    [Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. A randomized controlled trial]
    2004 ►
  16. Mitka Mike
    Vedno pogostejša uporaba statinov pri bolnikih z velikim tveganjem povzroča finančne preglavice
    [Expanding statin use to help more at-risk patients is causing financial heartburn]
    2004 ►
  17. Vrečer M; Turk S; Drinovec J; Mrhar A
    Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke: meta-analysis of randomized trials
    2003 ►
  18. Poredoš Pavel
    C-reaktivni protein, dejavnik tveganja za aterosklerozo in napovedovalec srčno-žilnih zapletov
    2003 ►
  19. Thompson Paul D; Clarkson Priscilla; Karas Richard H
    Miopatija, povezana z jemanjem statinov
    [Statin-associated myopathy]
    2003 ►
  20. Dugonik A; Belič M; Miljković J
    Eosinophilic fasciitis
    2003 ►
  21. Eidelman Rachel S; Lamas Gervasio A; Hennekens Charles H
    Nov državni program za izobraževanje o holesterolu: klinični izziv za bolj razširjeno uveljavitev protilipidnega zdravljenja in preprečevanja koronarne srčne bolezni
    [The new national cholesterol education program guidelines: clinical challenges for more widespread therapy of lipids to treat and prevent coronary heart disease]
    2003 ►
  22. Petrovič Uroš; Plemenitaš Ana
    Regulation of HMGCoA reductase activity by salt stress in Hortaea werneckii
    2003 ►
  23. Šebeštjen Miran; Boh Marko; Keber Irena
    Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia
    2002 ►
  24. Rozman Damjana; Waterman Michael R
    Sterol biosynthesis
    2002 ►
  25. Šebeštjen M; Žegura B; Keber I
    Both cerivastatin and fenofibrate improve arterial vasoreactivity in patients with combined hyperlipidaemia
    2002 ►
  26. Petrovič Uroš
    Mehanizmi adaptacije na spremembe slanosti okolja pri halofilni črni kvasovki Hortaea werneckii
    [Mechanisms of adaptation to changes in environmental salinity in a halophilic black yeast Hortaea werneckii]
    2001 ►
  27. Ray Joel G; Mamdani Muhamed; Tsuyuki Ross T; Anderson David R; Yeo Erik L; Laupacis Andreas
    Uporaba statinov in kasnejši nastanek globoke venske tromboze
    [Use of statins and the subsequent development of deep vein thrombosis]
    2001 ►
  28. Medvešček Marko
    Cardiac and renal protection in type 2 diabetes in view of recent relevant clinical trials: implications for clinical guidelines
    2001 ►
  29. Kanič Vojko
    Zdravljenje hiperlipidemij s statini
    2001 ►
  30. Kikelj Danijel
    Novi inhibitorji HMG-CoA-reduktaze
    [Novel inhibitors of HMG-CoA reductase]
    1999 ►
  31. Finderle Ž; Cankar K; Šebeštjen M; Keber I
    The effect of fenofibrat and cerivastatin on endothelium dependent and independent vasodilatation
    2000 ►
  32. Mrhar Aleš; Barbič-Žagar Breda
    Farmakoekonomski pogledi na zdravljenje s statini
    2000 ►
  33. Plemenitaš Ana; Watson John A
    Down-regulation of mammalian 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with highly purified liposomal cholesterol
    1999 ►
  34. Janežič Aleksander
    Prve izkušnje z Lescolom v Sloveniji
    1995 ►
  35. Reiner Željko; Vrbanec Damir
    Efficacy and safety of fluvastatin in hypertensive patients with hypercholesterolemia
    1995 ►
  36. Vlckova Eva
    Fluvastatin (LESCOL, Sandoz): a new statin in the treatment of hypercholesterolaemia
    1995 ►
  37. Keber Irena
    Agresivno zniževanje ravni holesterola v krvi - ali je dovolj dokazov za tak ukrep?
    1998 ►
  38. Gužič-Salobir B
    Zdravljenje z lipolitičnimi zdravili v sekundarni preventivi po srčnem infarktu
    1998 ►
  39. Rupreht Ruth
    Uravnavanje aktivnosti HMGCoA reduktaze v sistemu semi-intaktnih celic CHO-215
    1995 ►
  40. Petrovič U; Gunde-Cimerman N; Plemenitaš A
    Primerjava aktivnosti hidroksi-metil-glutaril koencim A reduktaze med ekstremofilnimi in mezofilno kvasovko
    1998 ►
  41. Rupreht R; Plemenitaš A
    Use of antibodies in the system of semi-intact cells
    [Uporaba protiteles v sistemu semi-intaktnih celic]
    1996 ►
  42. Plemenitaš A
    Semi-intaktne celice: eksperimentalni model za študij metaboličnih procesov
    [Semi-intact cells, an experimentalmodel for the studies of metabolic processes]
    1996 ►
  43. Gunde-Cimerman N; Cimerman A
    Pleurotus fruiting bodies contain the inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase-lovastatin
    1995 ►
  44. Gunde-Cimerman N; Friedrich J; Cimerman A; Benički N
    Screening fungi for the production of an inhibitor of HMG CoA reductase: production of mevinolin by the fungi of the genus Pleurotus
    1993 ►
  45. Tušek T; Rupreht R; Plemenitaš A
    Effect of farnesol on 3-hydroxy-3-methylglutaryl CoA reductase activity in semi-intact CHO-215 cells
    1995 ►
  46. Gunde-Cimerman N; Plemenitaš A; Cimerman A
    A hydroxymethylglutaryl-CoA reductase inhibitor synthesized by yeasts
    1995 ►
  47. Šircelj H
    Kvasovke, ki sintetizirajo inhibitor HMG-CoA reduktaze
    [Yeasts synthesizing the inhibitor of HMG-CoA reductase]
    1995 ►
  48. Koren D
    Submerzna biosinteza inhibitorja HMG CoA reduktaze z glivo Pleurotus sapidus
    [Submerged biosynthesis of HMG CoA reductaze inhibitor by Pleurotus sapidus]
    1994 ►
  49. Gunde-Cimerman N
    Glive, ki sintetizirajo inhibitor HMG-CoA reduktaze
    [Fungi synthesizing inhibitors of HMG-CoA reductase]
    1993 ►
  50. Keber I
    Hiperlipidemije
    1993 ►
  51. Gunde-Cimerman N; Plemenitaš A; Cimerman A
    Pleurotus fungi produce mevinolin, an inhibitor of HMG CoA reductase
    1993 ►
  52. Plemenitaš A; Havel CM; Watson JA
    Sterol-mediated regulation of mevalonic acid synthesis
    1990 ►
  53. Janežič A
    Zaviralci reduktaze HMG-CoA
    1990 ►
  54. Rumboldt Z
    Pogled na lovastatin in njegove sorodnike
    [Lovastatin and similar compounds]
    1990 ►


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics